Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Department of Physical Medicine and Rehabilitation, Harvard Medical School; Spaulding Rehabilitation Hospital and Spaulding Research Institute; MassGeneral Hospital for Children Sports Concussion Program; Home Base, A Red Sox Foundation and Massachusetts General Hospital Program, Boston, Massachusetts.
J Neurotrauma. 2019 Oct 15;36(20):2904-2912. doi: 10.1089/neu.2018.6351. Epub 2019 Jul 10.
The Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries in Adults (Scandinavian guidelines) are the first to incorporate serum measurement of the S100 astroglial calcium-binding protein B (S100B) to emergency department (ED) triage of patients with head injury (HI). This prospective validation study was conducted in the ED of the Tampere University Hospital, Finland, between November 2015 and November 2016. All consecutive adult patients with HI presenting to the ED within 24 h from injury were eligible for inclusion. Venous blood for S100B sampling was drawn from all patients, and the result was available at the ED. Computed tomography (CT) scans of the head were performed according to the on-call physician's evaluation. Only the samples collected within 6 h after injury were used. A one-week follow-up was conducted to identify possible HI-related complications. A total of 295 patients (median age, 67.0 years, range, 18-100; women, 48.8%) were enrolled. Of those, 196 (66.4%) underwent scanning. Acute traumatic lesions were detected on 31 (15.8%) of the scans. Two of the CT-positive patients were scanned without a guidelines-based indication. These lesions did not require any specific treatment or repeated imaging. The guidelines-based sensitivity was 0.94 (95% confidence interval [CI], 0.77-0.99) and specificity 0.19 (95% CI, 0.13-0.26) for predicting traumatic intracranial CT abnormalities. The positive and negative predictive value for positive head CT was 0.18 (95% CI, 0.12-0.25) and 0.94 (95% CI, 0.78-0.99), respectively. In the mild-low risk group, no false negative S100B values were recorded. Thirteen patients (4.4%) were re-admitted to the ED, and two patients (0.7%) died one week after the primary HI. The deaths were unrelated to the injury. None of these adverse events were directly caused by a primarily undiagnosed intracranial injury. The Scandinavian guidelines incorporated with S100B are a valid means of screening clinically significant acute traumatic lesions after HI and have the potential to reduce unnecessary CT scanning.
斯堪的纳维亚成人轻度、中度和重度头部损伤初步处理指南(斯堪的纳维亚指南)是首次将血清 S100 星形胶质细胞钙结合蛋白 B(S100B)测量纳入头部损伤(HI)患者的急诊分诊中。这项前瞻性验证研究于 2015 年 11 月至 2016 年 11 月在芬兰坦佩雷大学医院的急诊室进行。所有符合条件的 HI 成年患者在受伤后 24 小时内连续进入急诊室。所有患者均采集静脉血进行 S100B 采样,结果在急诊室获得。头部 CT 扫描根据随叫随到的医生的评估进行。仅使用损伤后 6 小时内采集的样本。进行了为期一周的随访以确定可能与 HI 相关的并发症。共纳入 295 例患者(中位数年龄 67.0 岁,范围 18-100 岁;女性 48.8%)。其中 196 例(66.4%)进行了扫描。31 例(15.8%)扫描显示急性创伤性病变。两名 CT 阳性患者未经指南指导进行了扫描。这些病变不需要任何特殊治疗或重复成像。基于指南的敏感性为 0.94(95%置信区间 [CI],0.77-0.99),特异性为 0.19(95%CI,0.13-0.26),用于预测创伤性颅内 CT 异常。阳性头部 CT 的阳性和阴性预测值分别为 0.18(95%CI,0.12-0.25)和 0.94(95%CI,0.78-0.99)。在轻度低危组中,未记录到假阴性 S100B 值。13 例患者(4.4%)因 ED 再次入院,2 例患者(0.7%)在原发性 HI 后一周死亡。死亡与损伤无关。这些不良事件均与未确诊的颅内损伤无关。纳入 S100B 的斯堪的纳维亚指南是筛选 HI 后临床显著急性创伤性病变的有效方法,有可能减少不必要的 CT 扫描。